Building New Solutions For 2023 In Manufacturing And Supply Chain
By Ben Comer, Chief Editor, Life Science Leader
Manufacturing and scaling the spate of new advanced therapeutics in development will continue to present a challenge in 2023, particularly as key supplies and ingredients remain sluggish to procure. Even so, biopharmaceutical executives contributing to this year’s industry outlook evince a confidence about the solutions they have devised from their respective perches along the value chain. In the following Q&A, 11 executives provide their thoughts on what the future holds for biopharmaceutical manufacturing and supply chain operations, and which issues will have the most impact.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.